TM-471-1

N/A

Report date: 2026/05/15 20:01:45
NME

Base Information

Drug NameTM-471-1
Drug Alias NameTM471-1TM-471-1
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase BTK inhibitors
TargetsTyrosine-protein kinase BTK
Therapy Area/IndicationsAutoimmune DiseasesChronic UrticariaEncephalitis +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesZhimicrobiological medicine (Xinxiang) Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesZhiwei Pharmaceutical Technology (Shanghai) Co LtdZhimicrobiological medicine (Xinxiang) Co LtdHenan Normal University
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesChronic UrticariaEncephalitis +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A